COSMO BIO COMPANY, LIMITED【JP:3386】Income statement

Market cap

¥7.9B

P/E ratio

33.8x

Cosmo Bio imports and sells life science research reagents and equipment to researchers at universities and corporations, offering over 10 million products from 500 companies worldwide.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	7,192	7,241	7,050	7,235	7,357	7,427	7,068	7,261	7,590	8,092	9,231	9,553	9,340	10,037	10,766
Revenue growth (%)	-
Cost of revenue	-	-	-	4,811	4,976	4,655	4,535	4,602	4,710	4,940	5,572	6,112	6,090	6,708	7,064
Gross profit	-	-	-	2,424	2,380	2,772	2,532	2,659	2,879	3,152	3,658	3,440	3,249	3,329	3,702
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	2,261	2,180	2,257	2,339	2,330	2,474	2,399	2,609	2,624	2,729	3,010	3,359
Operating income	-	-	-	162	200	514	193	328	405	752	1,048	816	519	318	343
Income before tax	856	801	444	285	373	483	397	403	470	817	1,099	790	653	364	489
Pretax margin (%)	11.9	11.1	6.3	3.9	5.1	6.5	5.6	5.6	6.2	10.1	11.9	8.3	7	3.6	4.5
Provision for income taxes	-	-	-	131	158	179	149	125	142	307	330	238	191	99	170
Effective tax rate (%)	-	-	-
Net income	458	411	313	201	230	276	250	278	246	701	768	552	461	269	337
Earnings per share	76.52	69.44	52.82	34.02	38.89	42.93	40.15	43.93	40.14	113.7	126.94	89.13	75.97	45.05	59.26
Dividend per share	-	-	-	-	-	-	-	-	14	34	36	36	30	50	50